@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PJSP1GMX-T
  skos:prefLabel "Parasympathomimétiques"@fr, "Parasympathomimetics"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-V8PVVLTL-J
  skos:prefLabel "Composés de béthanéchol"@fr, "Bethanechol Compounds"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-HNKB32B1-C .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-TGW16G8Q-4
  skos:prefLabel "Agonistes muscariniques"@fr, "Muscarinic Agonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-HNKB32B1-C
  skos:altLabel "2-Carbamoyloxypropyl-triméthylammonium"@fr, "004F72P8F4"@fr, "004F72P8F4"@en, "2-Carbamoyloxy-N,N,N-triméthylpropanaminium"@fr, "2-Carbamoyloxypropyl-triméthyl-ammonium"@fr, "2-Carbamoyloxy-N,N,N-triméthyl-propanaminium"@fr, "Bethanecol"@en, "674-38-4 (Bethanechol)"@fr, "674-38-4 (Bethanechol)"@en, "1-Propanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-"@fr, "1-Propanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-"@en, "H4QBZ2LO84"@fr, "H4QBZ2LO84"@en ;
  mesh:allowableQualifier jvr:-Q3979798-W, jvr:-XV06LPML-W, jvr:-W6SQV79N-S, jvr:-G30ZJ446-J, jvr:-THHNVC7V-3, jvr:-SBNWSM1T-R, jvr:-WK5F724J-1, jvr:-S0CS1X5R-5, jvr:-NB0XHT3S-N, jvr:-L6C0XPHT-4, jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-NKM836P1-M, jvr:-R0ZCQ8X6-J, jvr:-H7K65Q8S-Z, jvr:-NFTHND7Q-8, jvr:-M63HSDM7-1, jvr:-HQRFT0C6-B, jvr:-CB30NGKB-3, jvr:-TJHVZCRZ-0, jvr:-FWD2BGQ0-9, jvr:-T9HQD7ST-J, jvr:-NHL3D2X0-S, jvr:-BT300B3G-Q ;
  skos:hiddenLabel "Urocarb"@en, "Myotonachol"@en, "Bethanechol Chloride"@en, "Urecholine"@en, "Duvoid"@en, "Myocholine"@en, "Chlorure de béthanéchol"@fr, "Myotonine"@en, "PMS-Bethanechol Chloride"@en, "Myo Hermes"@en ;
  skos:inScheme jvr: ;
  dc:modified "2017-01-17"^^xsd:date ;
  skos:prefLabel "Bethanechol"@en, "Béthanéchol"@fr ;
  a skos:Concept, mesh:Descriptor ;
  dc:established "1995-01-01"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-TGW16G8Q-4, jvr:-PJSP1GMX-T ;
  dc:created "1994-06-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D018723> ;
  skos:broader jvr:-V8PVVLTL-J ;
  skos:definition "A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM."@en .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .